MANNKIND CORP Cash Flow Statement
MNKD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
MANNKIND CORP generated $18M in operating cash flow and $14M in free cash flow in FY2025. Free cash flow margin was 3.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $5.9M | $27.6M | -$11.9M | -$87.4M | -$80.9M | -$57.2M | -$51.9M | -$87.0M | -$117.3M | $125.7M | -$368.4M | -$198.4M | -$191.5M | -$169.4M | -$160.8M |
| Depreciation & Amortization | $12.3M | $7.4M | $4.5M | $3.3M | $2.0M | $2.1M | $972.0K | $2.9M | $1.8M | $2.4M | $11.0M | $9.8M | $11.5M | $13.0M | $14.6M |
| Operating Cash Flow | $18.3M | $42.5M | $34.1M | -$80.7M | -$61.7M | -$28.1M | -$88.5M | -$37.7M | -$64.8M | -$78.1M | -$57.2M | $4.1M | -$1.7B | -$119.9M | -$123.8M |
| Capital Expenditures | $4.6M | $9.7M | $42.4M | $7.6M | $11.5M | $801.0K | $2.6M | $354.0K | - | $1.1M | $10.3M | $24.1M | $8.0M | $637.0K | $6.9M |
| Free Cash Flow | $13.7M | $32.8M | -$8.3M | -$88.3M | -$73.2M | -$28.9M | -$91.0M | -$38.1M | - | -$79.2M | -$67.5M | -$20.0M | -$1.7B | -$120.5M | -$130.7M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | $1.0M | $1.0M | $1.0M |
| FCF Margin | 3.9% | 11.5% | -4.2% | -88.5% | -97.0% | -44.4% | -144.4% | -136.7% | - | -45.3% | - | - | - | -344277.1% | -261390.0% |